A carregar...
Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
17-alpha-hydroxyprogesterone caproate (17P) has been in use for prevention of recurrent preterm birth since 2003 when the Meis trial was published. A requirement for Food and Drug Administration approval of 17P was a confirmatory trial, called “PROLONG”, which was recently completed, but did not rep...
Na minha lista:
| Publicado no: | J Perinatol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group US
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049867/ https://ncbi.nlm.nih.gov/pubmed/33057132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41372-020-00849-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|